期刊论文详细信息
Molecular magnetic resonance imaging of atrial clots in a swine model
Article
关键词: CONTRAST AGENT;    IN-VIVO;    CORONARY-THROMBOSIS;    MRI;    ECHOCARDIOGRAPHY;    CARDIOVERSION;    FIBRILLATION;    APPENDAGE;    MASSES;    PLAQUE;   
DOI  :  10.1161/CIRCULATIONAHA.104.529941
来源: SCIE
【 摘 要 】

Background - The detection and differentiation of intracardiac masses is still challenging and may include neoplasms and thrombi. The aim of this study was the investigation of a targeted, fibrin-specific contrast agent (EP-2104R) for molecular targeted magnetic resonance imaging (MRI) of left atrial clots. Methods and Results - Chronic human thrombi were surgically implanted in the left atrial appendage of 5 swine. Molecular MRI was performed with a navigator-gated, free-breathing, cardiac-triggered 3D inversion-recovery, black-blood, gradient-echo sequence before and after systemic administration of 4 mu mol/kg EP-2104R. MR images were analyzed by 2 investigators, and the contrast-to-noise ratio was calculated. Location of clots was confirmed by autopsy, and the gadolinium concentration in the clots was assessed. Before contrast agent administration, thrombi were not visible on black-blood MR images. After contrast administration, all atrial clots ( n = 5) were selectively visualized as white spots with a high contrast-to-noise ratio (clot/blood, 29.7 +/- 8.0). The gadolinium concentration in the clots averaged 74 +/- 45 mu mol/L. Conclusions - The fibrin-specific MR contrast agent EP-2104R allows for selective and high-contrast visualization of left atrial clots by means of molecular targeted MRI.

【 授权许可】

Free   

  文献评价指标  
  下载次数:0次 浏览次数:2次